Persistent low-grade inflammation and regular exercise

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 1, 2010, Pages 96-105

  Astrom, Maj Briit ^a   Feigh, Michael ^a   Pedersen, Bente Klarlund ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Anti inflammation; Atherosclerosis; Cytokines; Exercise; Review

Indexed keywords

EID: 84883365354     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Libby P.: Inflammation in atherosclerosis. Nature 420, 868-74 (2002) (Pubitemid 36019640)
2. Libby P., P.M. Ridker & A. Maseri: Inflammation and atherosclerosis. Circulation 105, 1135-43 (2002) (Pubitemid 34212626)
3. Shishehbor M.H. & D.L. Bhatt: Inflammation and atherosclerosis. Curr Atheroscler Rep 6, 131-9 (2004) (Pubitemid 38914958)
4. Dandona P., A. Aljada & A. Bandy opadhy ay: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25, 4-7 (2004) (Pubitemid 38032801)
5. Sjoholm A, & T Nystrom: Inflammation and the aetiology of type 2 diabetes. Diabetes Metab Res Rev 22, 4-10 (2006)
6. Zipp F., & O. Aktas: The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends in Neurosciences 29, 518-27 (2006) (Pubitemid 44291819)
7. Cotman C.W., N.C. Berchtold & LA. Christie: Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends in Neurosciences 30, 464-72 (2007) (Pubitemid 47374831)
8. Ross R.: Atherosclerosis - an inflammatory disease. New Engl J med 340, 115-26 (1999) (Pubitemid 29054847)
9. Festa A., R. D'Agostino, R.P. Jr. Tracy & S.M. Haffner: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-7, (2002) (Pubitemid 34438360)
10. Handschin C., & B.M. Spiegelman: The role of exercise and PGC1 (alpha) in inflammation and chronic disease. Nature 454, 463-9 (2008)
11. Hotamisligil G.S.: Inflammation and metabolic disorders. Nature 444, 860-7 (2006) (Pubitemid 46024993)
12. Haffner S.M.: The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease. The American Journal of Cardiology 97, 3-11 (2006)
13. Matter C.M., & C. Handschin: RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted), Inflammation, Obesity, and the Metabolic Syndrome. Circulation 115, 946-8 (2007) (Pubitemid 46328286)
14. Perry V.H., C. Cunningham & C. Holmes: Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7, 161-7 (2007) (Pubitemid 46174862)
15. Nocon M., T. Hiemann, F. Muller-Riemenschneider, F. Thalau, S. Roll & S.N. Willich: Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15, 239-46 (2008)
16. Kokkinos P.: Physical Activity and Cardiovascular Disease Prevention: Current Recommendations. Angiology 59, 26S-29S (2008)
17. Tuomilehto J., J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen & M. Uusitupa: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343-50 (2001) (Pubitemid 32378388)
18. Knowler W.C., E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker & D.M. Nathan: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403 (2002) (Pubitemid 34437694)
19. Lindstrom J., P. Ilanne-Parikka, M. Peltonen, S. Aunola, J.G. Eriksson, K. Hemio, H. Hämäläinen, P. Härkönen, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Mannelin, M. Paturi, J. Sundvall, T.T. Valle, M. Uusitupa & J. Tuomilehto: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368, 1673-9 (2006) (Pubitemid 46048554)
20. Boule N.G., E. Haddad, G.P. Kenny, G.A. Wells & R.J. Sigal: Effects of exercise on glycaemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286, 1218-27 (2001) (Pubitemid 33015552)
21. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-65 (1998)
22. Coutinho M., H.C. Gerstein, Y. Wang & S. Yusuf: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years. Diabetes Care 22, 233-40 (1999) (Pubitemid 29056916)
23. Bruunsgaard H., M. Pedersen & B.K. Pedersen: Aging and proinflammatory cytokines. Curr Opin Hematol 8, 131-6 (2001) (Pubitemid 32324632)
24. Allen K.V., B.M. Frier, & M.W. Strachan: The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490, 169-75 (2004) (Pubitemid 38482170)
25. Biessels G.J., S. Staekenborg, E. Brunner, C. Brayne & P. Scheltens: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5, 64-74 (2006) (Pubitemid 41790697)
26. Rovio S., I. Kareholt, E.L. Helkala, M. Viitanen, B. Winblad, J. Tuomilehto, H. Soininen, A. Nissinen & M. Kivipelto: Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4, 705-11 (2005) (Pubitemid 41457285)
27. Andel R., M. Crowe, N.L. Pedersen, L. Fratiglioni, B. Johansson & M. Gatz: Physical Exercise at Midlife and Risk of Dementia Three Decades Later: a population-based study of Swedish twins. J Gerontol A Biol Sci Med Sci 63, 62-6 (2008) (Pubitemid 351738465)
28. Lautenschlager N.T., K.L. Cox, L. Flicker, J.K. Foster, F.M. van Bockxmeer, J. Xiao, K.R. Greenop & O.P. Almeida: Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 300, 1027-37 (2008)
29. Abramson J.L. & V. Vaccarino: Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 162, 1286-92 (2002) (Pubitemid 34595035)
30. Geffken D.F., M. Cushman, G.L. Burke, J.F. Polak, P.A. Sakkinen & R.P. Tracy: Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 153, 242-50 (2001) (Pubitemid 32958648)
31. King D.E., P. Carek, A.G. Mainous III & W.S. Pearson: Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 35, 575-81 (2003) (Pubitemid 36417846)
32. Smith J.K., R. Dykes, J.E. Douglas, G. Krishnaswamy & S. Berk: Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281, 1722-7 (1999) (Pubitemid 29226483)
33. Taaffe D.R., T.B. Harris, L. Ferrucci, J. Rowe & T.E. Seeman: Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 55, M709-M715 (2000) (Pubitemid 32175753)
34. Wannamethee S.G., G.D. Lowe, P.H. Whincup, A. Rumley, M. Walker & L. Lennon: Physical activity and haemostatic and inflammatory variables in elderly men. Circulation 105, 1785-90 (2002) (Pubitemid 34408887)
35. Bruunsgaard H., S. Ladelund, A.N. Pedersen, M. Schroll, T. Jorgensen & B.K. Pedersen: Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132, 24-31 (2003) (Pubitemid 36418902)
36. Tisi P.V., M. Hulse, A. Chulakadabba, P. Gosling & C.P. Shearman: Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 14, 344-50 (1997) (Pubitemid 27511417)
37. Fallon K.E., S.K. Fallon & T. Boston: The acute phase response and exercise: court and field sports. Br J Sports Med 35, 170-3 (2001) (Pubitemid 32973432)
38. Mattusch F., B. Dufaux, O. Heine, I. Mertens & R. Rost: Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 21, 21-4 (2000) (Pubitemid 30066080)
39. Tchernof A., A. Nolan, C.K. Sites, P.A. Ades & E.T. Poehlman: Weight Loss Reduces C-reactive protein Levels in Obese Postmenopausal Women. Circulation 105, 564-9 (2002) (Pubitemid 34123429)
40. Ziccardi P., F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, F. D'Andrea, A.M. Molinari & D. Giugliano: Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year. Circulation 105, 804-9 (2002) (Pubitemid 34174919)
41. Roytblat L., M. Rachinsky, A. Fisher, L. Greemberg, Y. Shapira, A. Douvdevani & S. Gelman: Raised Interleukin-6 Levels in Obese Patients. Obesity 8, 673-5 (2000)
42. Marfella R., K. Esposito, M. Siniscalchi, F. Cacciapuoti, F. Giugliano, D. Labriola, M. Ciotola, C. Di Palo, L. Misso & D. Giugliano: Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women. Diabetes Care 27, 47-52 (2004) (Pubitemid 38196708)
43. Dandona P., R. Weinstock, K. Thusu, E. bdel-Rahman, A. Aljada & T. Wadden: Tumor Necrosis Factor-alpha in Sera of Obese Patients: Fall with Weight Loss. Journal of Clinical Endocrinology Metabolism 83, 2907-10 (1998) (Pubitemid 28493796)
44. Esposito K., A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti & D. Giugliano: Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87, 3864-6 (2002) (Pubitemid 34879540)
45. Monzillo L.U., O. Hamdy, E.S. Horton, S. Ledbury, C. Mullooly, C. Jarema, S. Porter, K. Ovalle, A. Moussa & C.S. Mantzoros: Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance. Obesity 11, 1048-54 (2003) (Pubitemid 41151581)
46. Seshadri P., N. Iqbal, L. Stern, M. Williams, K.L. Chicano, D.A. Daily, J. McGrory, E.J. Gracely, D.J. Rader & F.F. Samaha: A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. The American Journal of Medicine 117, 398-405 (2004) (Pubitemid 39369544)
47. Herder C., M. Peltonen, W. Koenig, K. Sutfels, J. Lindstrom, S. Martin, P. Ilanne-Parikka, J.G. Eriksson, S. Aunola, S. Keinänen-Kiukaanniemi, T.T. Valle, M. Uusitupa, H. Kolb & J. Tuomilehto: Finnish Diabetes Prevention Study Group: Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52, 433-42 (2009)
48. Nieman D.C.: Current perspective on exercise immunology. Curr Sports Med Rep 2, 239-42 (2003)
49. Gleeson M.: Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev 6, 5-42 (2000) (Pubitemid 30445600)
50. Sakurai T, T. Izawa, T. Kizaki, J.E. Ogasawara, K. Shirato, K. Imaizumi, K. Takahashi, H. Ishida & H. Ohno: Exercise training decreases expression of inflammation-related adipokines through reduction of oxidative stress in rat white adipose tissue. Biochemical and Biophysical Research Communications 379, 605-9 (2009)
51. Lira F.S., J.C. Rosa, A.S. Yamashita, C.H. Koyama, J. Batista & M. Seelaender: Endurance training induces depot-specific changes in IL-10/TNF-(alpha) ratio in rat adipose tissue. Cytokine 45, 80-5 (2009)
52. Bradley R.L., J.Y. Jeon, F.F. Liu & E. Maratos-Flier: Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 295, E586-E594 (2008)
53. Lambert C.P., N.R. Wright, B.N. Finck & D.T. Villareal: Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. Journal of Applied Physiology 105, 473-8 (2008)
54. Zhang C., K.M. Rexrode, R.M. van Dam, T.Y. Li & F.B. Hu: Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality: Sixteen Years of Follow-Up in US Women. Circulation 117, 1658-67 (2008) (Pubitemid 351482590)
55. Castell L.M., J.R. Poortmans, R. Leclercq, M. Brasseur, J. Duchateau & E.A. Newsholme: Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol Occup Physiol 75, 47-53 (1997) (Pubitemid 27029622)
56. Beydoun M.A., H.A. Beydoun & Y. Wang: Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 9, 204-18 (2008) (Pubitemid 351550691)
57. Pischon T., H. Boeing, K. Hoffmann, M. Bergmann, M.B. Schulze, K. Overvad, Y.T. van der Schouw, E. Spencer, K.G. Moons, A. Tjønneland, J. Halkjaer, M.K. Jensen, J. Stegger, F. Clavel-Chapelon, M.C. Boutron-Ruault, V. Chajes, J. Linseisen, R. Kaaks, A. Trichopoulou, D. Trichopoulos, C. Bamia, S. Sieri, D. Palli, R. Tumino, P. Vineis, S. Panico, P.H. Peeters, A.M. May, H.B. Bueno-de-Mesquita, F.J. van Duijnhoven, G. Hallmans, L. Weinehall, J. Manjer, B. Hedblad, E. Lund, A. Agudo, L. Arriola, A. Barricarte, C. Navarro, C. Martinez, J.R. Quirós, T. Key, S. Bingham, K.T. Khaw, P. Boffetta, M. Jenab, P. Ferrari & E. Riboli: General and Abdominal Adiposity and Risk of Death in Europe. The New England Journal of Medicine 359, 2105-20 (2008)
58. You T. & B.J. Nicklas: Chronic inflammation: role of adipose tissue and modulation by weight loss. Curr Diabetes Rev 2, 29-37 (2006) (Pubitemid 44082948)
59. Yudkin J.S.: Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 39, 707-9 (2007) (Pubitemid 350099816)
60. Mohamed-Ali V., S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles & J.S. Yudkin, S. Klein & S.W. Coppack: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-200 (1997) (Pubitemid 27525539)
61. Kay S.J., M.A. Fiatarone Singh: The influence of physical activity on abdominal fat: a systematic review of the literature. Obes Rev 7, 183-200 (2006)
62. Lee C.G., M.C. Carr, S.J. Murdoch, E. Mitchell, N.F. Woods, M.H. Wener, W.L. Chandler, E.J. Boyko & J.D. Brunzell: Adipokines, Inflammation, and Visceral Adiposity Across The Menopausal Transition: A Prospective Study. Journal of Clinical Endocrinology Metabolism Jan 6 (2009) Epub ahead.
63. Kanaley J.A., C. Sames, L. Swisher, A.G. Swick, L.L. Ploutz-Snyder, C.M. Steppan, K.S. Sagendorf, D. Feiglin, E.B. Jaynes, R.A. Meyer & R.S. Weinstock: Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 50, 976-82 (2001) (Pubitemid 32755016)
64. Starkie R., S.R. Ostrowski, S. Jauffred, M. Febbraio, B.K. Pedersen: Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 17, 884-6 (2003)
65. Pedersen B.K. & L. Hoffman-Goetz: Exercise and the immune system: regulation, integration and adaptation. Physiol Rev 80, 1055-81 (2000) (Pubitemid 30452011)
66. Suzuki K., S. Nakaji, M. Yamada, M. Totsuka, K. Sato & K. Sugawara: Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 8, 6-48 (2002)
67. Febbraio M.A. & B.K. Pedersen: Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335-47 (2002) (Pubitemid 34913306)
68. Pedersen B.K., A. Steensberg & P. Schjerling: Muscle-derived interleukin-6: possible biological effects. J Physiol 536, 329-37 (2001) (Pubitemid 32976115)
69. Pedersen B.K. & A.D. Toft: Effects of exercise on lymphocytes and cytokines. Br J Sports Med 34, 246-51 (2000) (Pubitemid 30609522)
70. Pedersen B.K. & M.A. Febbraio: Muscle as an endocrine organ - focus on muscle-derived IL-6. Physiol Rev 88, 1379-406 (2008)
71. Saghizadeh M., J.M. Ong, W.T. Garvey, R.R. Henry, & P.A. Kern: The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97, 1111-6 (1996) (Pubitemid 26070591)
72. Feingold K.R. & C. Grunfeld: Role of cytokines in inducing hyperlipidemia. Diabetes 41, 97-101 (1992)
73. Mishima Y., A. Kuyama, A. Tada, K. Takahashi, T. Ishioka & M. Kibata: Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 52, 119-23 (2001) (Pubitemid 32366481)
74. Winkler G., F. Salamon, G. Harmos, D. Salamon, G. Speer, O. Szekeres, P. Hajós, M. Kovács, K. Simon & K. Cseh: Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. Diabetes Res Clin Pract 42, 169-74 (1998) (Pubitemid 29009777)
75. Coppack S.W.: Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60, 349-56 (2001) (Pubitemid 32772450)
76. Hotamisligil G.S., N.S. Shargill & B.M. Spiegelman: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993) (Pubitemid 23036092)
77. Halse R., S.L. Pearson, J.G. McCormack, S.J. Yeaman & R. Taylor: Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 50, 1102-9 (2001) (Pubitemid 32374541)
78. Youd J.M., S. Rattigan & M.G. Clark: Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49, 1904-9 (2000)
79. Staels B., W. Koenig, A. Habib, R. Merval, M. Lebret, I.P. Torra, P. Delerive, A. Fadel, G. Chinetti, J.C. Fruchart, J. Najib, J. Maclouf & A. Tedgui: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393, 790-3 (1998) (Pubitemid 28299490)
80. Borst S.E. & G.J. Bagby: Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats. Metabolism 51, 1061-4 (2002)
81. Hotamisligil G.S.: Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 107, 119-25 (1999)
82. Hotamisligil G.S., P. Peraldi, A. Budavari, R. Ellis, M.F. White & B.M. Spiegelman: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-8 (1996) (Pubitemid 26052915)
83. Peraldi P., G.S. Hotamisligil, W.A. Buurman, M.F. White & B.M. Spiegelman: Tumor necrosis factor (TNF)-alpha inhibits insulin signalling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271, 13018-22 (1996)
84. Plomgaard P., K. Bouzakri, R. Krogh-Madsen, J.R. Zierath & B.K. Pedersen: TNF-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of AS160 phosphorylation. Diabetes 54, 2939-45 (2005) (Pubitemid 41401090)
85. Botion L.M., A.R. Brasier, B. Tian, V. Udupi & A. Green: Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G (i) proteins and stimulate lipolysis. Endocrinology 142, 5069-75 (2001) (Pubitemid 33131932)
86. Gasic S., B. Tian & A. Green: Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 274, 6770-5 (1999) (Pubitemid 29111100)
87. Green A., S.B. Dobias, D.J. Walters & A.R. Brasier: Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormonesensitive lipase. Endocrinology 134, 2581-8 (1994) (Pubitemid 24170874)
88. Souza S.C., M.T. Yamamoto, M.D. Franciosa, P. Lien & A.S. Greenberg: BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 47, 691-5 (1998) (Pubitemid 28160464)
89. Souza S.C., L.M. de Vargas, M.T. Yamamoto, P. Lien, M.D. Franciosa, L.G. Moss, A.S. Greenberg: Over expression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273, 24665-9 (1998) (Pubitemid 28454965)
90. Ryden M., A. Dicker, V. van Harmelen, H. Hauner, M. Brunnberg, L. Perbeck, F. Lonnqvist & P. Arner: Mapping of early signalling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem 277, 1085-91 (2002) (Pubitemid 34968854)
91. Zhang H.H., M. Halbleib, F. Ahmad, V.C. Manganiello & A.S. Greenberg: Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51, 2929-35 (2002)
92. Botion L.M., A.R. Brasier, B. Tian, V. Udupi & A. Green: Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G (i) proteins and stimulate lipolysis. Endocrinology 142, 5069-75 (2001) (Pubitemid 33131932)
93. Souza S.C., L.M. de Vargas, M.T. Yamamoto, P. Lien, M.D. Franciosa, L.G. Moss, A.S. Greenberg: Over expression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 273, 24665-9 (1998) (Pubitemid 28454965)
94. Ogawa H., S. Nielsen & M. Kawakami: Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1003, 131-5 (1989) (Pubitemid 19145428)
95. Rahn-Landstrom T., J. Mei, M. Karlsson, V. Manganiello & E. Degerman: Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP. Biochem J 346, 337-43 (2000) (Pubitemid 30148118)
96. Bruce C.R. & D.J. Dyck: Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 287, E616-E621 (2004) (Pubitemid 39237888)
97. Yudkin J.S., E. Eringa & C.D. Stehouwer: "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365, 1817-20 (2005) (Pubitemid 40744663)
98. Plomgaard P., P. Keller, C. Keller & B.K. Pedersen: TNF-alpha, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J Appl Physiol 98, 2019-23 (2005) (Pubitemid 40726892)
99. Hotamisligil G.S.: Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27, S53-S55 (2003) (Pubitemid 38019190)
100. Pickup J.C., M.B. Mattock, G.D. Chusney & D. Burt: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286-92 (1997) (Pubitemid 27469668)
101. Petersen K.F., S. Dufour, D. Befroy, R. Garcia & G.I. Shulman: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350, 664-71 (2004) (Pubitemid 38364625)
102. Carey A.L., C.R. Bruce, M. Sacchetti, M.J. Anderson, D. Olson, B. Saltin, J.A. Hawley & M.A. Febbraio: Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma IL-6 is related to fat mass and not insulin responsiveness. Diabetologia 47, 1029-37 (2004) (Pubitemid 38918162)
103. Steensberg A., C.P. Fischer, M. Sacchetti, C. Keller, T. Osada, P. Schjerling, G. van Hall, M.A. Febbraio & B.K. Pedersen: Acute interleukin-6 administration does not impair muscle glucose uptake or whole body glucose disposal in healthy humans. J Physiol 548, 631-8 (2003) (Pubitemid 36527483)
104. Lyngso D., L. Simonsen & J. Bulow: Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543, 373-8 (2002) (Pubitemid 34947322)
105. Febbraio M.A., N. Hiscock, M. Sacchetti, C.P. Fischer & B.K. Pedersen: Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643-8 (2004) (Pubitemid 38864744)
106. Petersen E.W., A.L. Carey, M. Sacchetti, G.R. Steinberg, S.L. Macaulay, M.A. Febbraio, B.K. Pedersen: Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol 288, E155-E162 (2005) (Pubitemid 40023802)
107. Rotter V., I. Nagaev & U. Smith: Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278, 45777-84 (2003) (Pubitemid 37432722)
108. Kim H.J., T. Higashimori, S.Y. Park, H. Choi, J. Dong, Y.J. Kim, H.L. Noh, Y.R. Cho, G. Cline, Y.B. Kim & J.K. Kim: Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo. Diabetes 53, 1060-7 (2004) (Pubitemid 38436619)
109. Wallenius V., K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S.L. Dickson, C. Ohlsson, J.O. Jansson: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8, 75-9 (2002) (Pubitemid 34101732)
110. Carling D.: The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29, 18-24 (2004) (Pubitemid 38068476)
111. Kelly M., C. Keller, P.R. Avilucea, P. Keller, Z. Luo, X. Xiang, M. Giralt, J. Hidalgo, A.K. Saha, B.K. Pedersen & N.B. Ruderman: AMPK activity is diminished in tissues of the IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 320, 449-54 (2004) (Pubitemid 38798888)
112. Stouthard J.M., J.A. Romijn, T. Van der Poll, E. Endert, S. Klein, P.J. Bakker, C.H. Veenhof & H.P. Sauerwein: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268, E813-E819 (1995)
113. Path G., S.R. Bornstein, M. Gurniak, G.P. Chrousos, W.A. Scherbaum & H. Hauner: Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 86, 2281-8 (2001) (Pubitemid 32472953)
114. Nonogaki K., G.M. Fuller, N.L. Fuentes, A.H. Moser, I. Staprans, C. Grunfeld & K.R. Feingold: Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136, 2143-9 (1995)
115. van Hall G., A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, N. Hiscock, K. Møller, B. Saltin B, M.A. Febbraio & B.K. Pedersen: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88, 3005-10 (2003) (Pubitemid 36877463)
116. Pedersen M., H. Bruunsgaard, N. Weis, H.W. Hendel, B.U. Andreassen, E. Eldrup, F. Dela & B.K. Pedersen: Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124, 495-502 (2003) (Pubitemid 36514904)
117. Mohamed-Ali V., S. Goodrick, K. Bulmer, J.M. Holly, J.S. Yudkin & S.W. Coppack: Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277, E971-E975 (1999) (Pubitemid 30045988)
118. Fried S.K., D.A. Bunkin & A.S. Greenberg: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847-50 (1998) (Pubitemid 28496456)
119. Coppack S.W.: Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60, 349-56 (2001) (Pubitemid 32772450)
120. Tsigos C., I. Kyrou, E. Chala, P. Tsapogas, J.C. Stavridis & S.A. Raptis: Circulating tumour necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48, 1332-5 (1999) (Pubitemid 29496085)